• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Surgeons pilot expandable prosthetic valves for children with congenital heart disease

Cardiology, valves, 26 August 2020/in E-News /by 3wmedia

Surgeons at Boston Children’s Hospital have successfully implanted a modified version of a expandable prosthetic heart valve in several children with mitral valve disease. Unlike traditional prosthetic valves that have a fixed diameter, the expandable valve can be enlarged as a child grows, thus potentially avoiding the repeat valve replacement surgeries that are commonly required in a growing child. The new paradigm of expandable mitral valve replacement has potential to revolutionise care for infants and children with complex mitral valve disease.

The surgical team, led by Sitaram M. Emani, MD, and Pedro J. del Nido, MD, of the Department of Cardiac Surgery at Boston Children’s, have summarised their outcomes with two patients.

The care of patients with disease of the mitral valve

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:42:192023-09-06 08:35:06Surgeons pilot expandable prosthetic valves for children with congenital heart disease

Uncertain about health outcomes, male stroke survivors more likely to suffer depression than females

, 26 August 2020/in E-News /by 3wmedia

Post-stroke depression is a major issue affecting approximately 33% of stroke survivors. A new study reports that the level to which survivors are uncertain about the outcome of their illness is strongly linked to depression. The relationship is more pronounced for men than for women.
‘Male stroke survivors in the US who subscribe to traditional health-related beliefs may be accustomed to, and value highly, being in control of their health,’ says lead investigator Michael J. McCarthy, PhD, of the University of Cincinnati College of Health Sciences School of Social Work. ‘For these individuals, loss of control due to infirmity caused by stroke could be perceived as a loss of power and prestige. These losses, in turn, may result in more distress and greater depressive syndromes.’
Thirty-six survivors (16 female, 20 male) who had experienced their first stroke within the preceding 36 months participated in the study. Survivors’ depressive symptoms and ability to perform activities of daily living, such as bathing and cutting food with a knife and fork, were measured. The degree to which survivors were experiencing health ambiguity, or uncertainty about the outcomes of their illness, was evaluated by their agreement with statements such as ‘I don’t know what’s wrong with me,’ and ‘I have a lot of questions without answers.’
Investigators found health ambiguity was significantly associated with greater depression for both sexes, and the association was stronger for male survivors than for females. ‘These findings suggest that reducing health ambiguity through proactive communication with patients and family members may be an effective approach for reducing survivor distress and, ultimately, for improving rehabilitation outcomes, Dr. McCarthy says. ‘The also reinforce the importance of rehabilitation professionals acknowledging that health-related beliefs can have a tangible impact on patient outcomes.’
Dr. McCarthy notes that there was a wide variability in time since diagnosis in the study, and patients were likely at different points in recovery with respect to health ambiguity and depressive syndromes. The small sample size and lack of sample diversity may limit the generalisability of the findings to the broader stroke population. ‘Future research, with more socio-economically diverse samples, should examine how gender-based health-related beliefs affect survivor outcomes, and explore the factors that protect female stroke survivors from the harmful effects of health ambiguity,’ he concludes. EurekAlert

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:42:192020-08-26 14:42:30Uncertain about health outcomes, male stroke survivors more likely to suffer depression than females

Yoga proves to reduce depression in pregnant women, boost maternal bonding

, 26 August 2020/in E-News /by 3wmedia

It

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:42:192020-08-26 14:42:34Yoga proves to reduce depression in pregnant women, boost maternal bonding

Questionnaire completed by parents may help identify 1-year-olds at risk for autism

, 26 August 2020/in E-News /by 3wmedia

A new study by University of North Carolina School of Medicine researchers found that 31 percent of children identified as at risk for autism spectrum disorders (ASD) at 12 months received a confirmed diagnosis of ASD by age 3 years.
In addition, 85 percent of the children found to be at risk for ASD based on results from the First Year Inventory (FYI), a 63-item questionnaire filled out by their parents, had some other developmental disability or concern by age three, said Grace Baranek, PhD, senior author of the study and an autism researcher with the Program for Early Autism, Research, Leadership and Service (PEARLS) in the Department of Allied Health Sciences at the UNC School of Medicine.
‘These results indicate that an overwhelming majority of children who screen positive on the FYI indeed experience some delay in development by age three that may warrant early intervention,’ she said.
Lead author of the study, Lauren Turner-Brown, PhD, also a researcher with PEARLS and the Carolina Institute for Developmental Disabilities said, ‘Identification of children at risk for ASD at 12 months could provide a substantial number of children and their families with access to intervention services months or years before they would otherwise receive a traditional diagnosis.’
The First Year Inventory was developed by Grace Baranek, PhD, Linda Watson, EdD, Elizabeth Crais, PhD and J. Steven Reznick, PhD, who are all researchers with PEARLS. All are also co-authors of the study with Turner-Brown, published online ahead of print.
In the study, parents of 699 children who had completed the FYI when their child was 12 months old completed additional screening questionnaires when their child reached age 3. In addition, children who were found to be at risk for ASD based on these measures were invited for in-person diagnostic evaluations.
‘These findings are encouraging and suggest promise in the approach of using parent report of infant behaviours as a tool for identifying 12-month-olds who are at risk for an eventual diagnosis of ASD,’ Turner-Brown said. University of North Carolina Health Care

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:42:192020-08-26 14:42:38Questionnaire completed by parents may help identify 1-year-olds at risk for autism

Mount Sinai performs first imaging test to detect Alzheimer’s Disease

, 26 August 2020/in E-News /by 3wmedia

The Mount Sinai Medical Center is the first institution in New York State to use in the clinical setting a newly approved imaging technique to detect Alzheimer’s disease (AD) in people who are cognitively impaired. Until now, physicians have been limited in their ability to diagnose AD, guided almost exclusively by a patient’s mental and behavioural symptoms and family history. The innovative technique

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:42:192020-08-26 14:42:41Mount Sinai performs first imaging test to detect Alzheimer’s Disease

Heartbeat ‘could power pacemaker’

, 26 August 2020/in E-News /by 3wmedia

Currently repeated operations are needed to replace batteries in pacemakers, but according to US researchers a device which could harness energy from a beating heart can produce enough electricity to keep a pacemaker running.
Piezoelectric materials generate an electric charge when their shape is changed. They are used in some microphones to convert vibrations into an electrical signal. Researchers at the University of Michigan are trying to use the movement of the heart as a source of electricity.

In tests designed to simulate a range of heartbeats, enough electricity was generated to power a pacemaker. Tests suggested the device could produce 10 times the amount of energy needed. The designers now want to test the device on a real heart and build it into a commercial pacemaker.

The British Heart Foundation said clinical trials were needed to show it would be safe for patients.

Dr Amin Karami told a meeting of the American Heart Association that pacemaker batteries needed to be replaced approximately every seven years. ‘Many of the patients are children who live with pacemakers for many years. You can imagine how many operations they are spared if this new technology is implemented.’

Prof Peter Weissberg, the medical director at the British Heart Foundation, said: ‘Advancing technology over recent years has meant people with pacemakers need to change their battery less often. This device could be another step forward along this path. ‘If researchers can refine the technology and it proves robust in clinical trials, it would further reduce the need for battery changes.’

BBC
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:42:192020-08-26 14:42:23Heartbeat ‘could power pacemaker’

Study reveals ‘unacceptably high’ hip resurfacing failure rates

, 26 August 2020/in E-News /by 3wmedia

Hip resurfacing – an alternative to hip replacement often recommended to younger patients – is prone to early failure in many instances, and should not be used in women, according to a study led by the University of Bristol.
The observational study, conducted on behalf of the National Joint Registry for England and Wales, examined data from 434,650 hip operations undertaken between April 2003 and September 2011, of which 31,932 (7.3 per cent) were resurfacings. The research looked at how many resurfacing implants failed in the first seven years after surgery and whether the head size of the implant affected failure rates. Patients with resurfacing were also compared with those who had undergone hip replacement with other bearing surfaces.
Hip resurfacing is similar to total hip replacement, except the femoral head (the rounded top section of the thigh bone) is not completely removed. Instead, the superficial bone is removed and replaced with a metal cap. Hip resurfacings always have metal-on-metal bearings, whilst total hip replacements can have a variety of bearing options, such as ceramic, metal, or plastic. Resurfacing is often offered to younger patients as an alternative to hip replacement, but is also commonly used in older patients.
The researchers found that the use of smaller head sizes was linked to higher failure rates and in most cases, resurfacing implants failed more quickly than other bearing surfaces. The only exception to this was for men with a large (≥ 54mm) femoral head, who showed comparable rates of implant success to those who had undergone total hip replacement. This group constituted only 23 per cent (5,085) of the total resurfacing operations in men during the period studied. Women who underwent hip resurfacing experienced particularly poor implant survival, with failure rates up to five times higher than other bearing surfaces.
According to Ashley Blom, Professor of Orthopaedic Surgery in the University

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:42:192020-08-26 14:42:26Study reveals ‘unacceptably high’ hip resurfacing failure rates

Intervention helps children with sickle cell disease complete MRI tests without sedation

, 26 August 2020/in E-News /by 3wmedia

Sitting still is tough for children, which makes MRI scans a challenge. The scans require that patients remain motionless for extended periods. Findings from St. Jude Children

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:42:192020-08-26 14:42:30Intervention helps children with sickle cell disease complete MRI tests without sedation

Patients want more risks disclosed before treatment

, 26 August 2020/in E-News /by 3wmedia

A study showed that some doctors, particularly surgeons, are not explaining the risk of specific outcomes that matter most to patients. Overlooked risks that led to a legal claim or complaint included chronic pain, sexual dysfunction, visual or hearing loss, and the need for re-operation.

Lead author Dr Marie Bismark from the University of Melbourne School of Population Health said the study revealed that doctors may routinely underestimate the importance patients place on understanding certain risks in advance of treatment.

‘Increasingly, doctors are expected to advise and empower patients to make rational choices by sharing information that may affect treatment decisions, including risks of adverse outcomes,’ she said.

‘However, doctors, especially surgeons, are often unsure which clinical risks they should disclose and discuss with patients before treatment and this is reflected in this study.’

The authors found that the most common justifications doctors gave for not telling patients about particular risks before treatment were that they considered such risks too rare to warrant discussion, or that the specific risk was covered by a more general risk that was discussed.

‘It is not necessary, or helpful, for doctors to provide a laundry list of all possible risks. Instead, doctors should focus on discussing those risks which are likely to matter most to the patient before them,’ she said.

From a sample of nearly 10,000 patient complaints and malpractice claims from Australia between 2001 and 2008, researchers identified 481 disputes involving alleged deficiencies in obtaining informed consent.

The authors found that 45 (9%) of the cases studied were disputed duty cases

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:42:192020-08-26 14:42:34Patients want more risks disclosed before treatment

Elegant Delivery

, 26 August 2020/in E-News /by 3wmedia

Cancers are notorious for secreting chemicals that confuse the immune system and thwart biological defences.
To counter that effect, some cancer treatments try to neutralise the cancer’s chemical arsenal and boost a patient’s immune response–though attempts to do both at the same time are rarely successful.
Now, researchers have developed a novel system to simultaneously deliver a sustained dose of both an immune-system booster and a chemical to counter the cancer’s secretions, resulting in a powerful therapy that, in mice, delayed tumour growth, sent tumours into remission and dramatically increased survival rates.
The new immunotherapy incorporates well-studied drugs, but delivers them using nanolipogels (NLGs), a new drug transport technology the researchers designed. The NLGs are nanoscale, hollow, biodegradable spheres, each one capable of accommodating large quantities of chemically diverse molecules.
The spheres appear to accumulate in the leaky vasculature, or blood vessels, of tumours, releasing their cargo in a controlled, sustained fashion as the spherule walls and scaffolding break down in the bloodstream.
For the recent experiments, the NLGs contained two components: an inhibitor drug that counters a particularly potent cancer defence called transforming growth factor-β (TGF-β), and interleukin-2 (IL-2), a protein that rallies immune systems to respond to localised threats.
‘You can think of the tumour and its microenvironment as a castle and a moat,’ says Tarek Fahmy, the Yale University engineering professor and NSF
CAREER grantee who led the research. "The ‘castles’ are cancerous tumours, which have evolved a highly intelligent structure–the tumour cells and vasculature. The ‘moat’ is the cancer’s defence system, which includes TGF-β. Our strategy is to ‘dry-up’ that moat by neutralising the TGF-β. We do that using the inhibitor that is released from the nanolipogels. The inhibitor effectively stops the tumour

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:42:192020-08-26 14:42:38Elegant Delivery
Page 75 of 240«‹7374757677›»

Latest issue of International Hospital

April 2024

2 June 2026

DeepHealth achieves multiple regulatory milestones for Neuro, Prostate and LumbarMR

7 January 2026

Gulf Aorta Summit 2026 Returns to Dubai with a Global Lineup of Aortic Experts

17 December 2025

GE HealthCare receives CE mark for 128cm total body PET/CT

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription